|
|
||||||||
From the Departments of Neurosciences (Drs. Antonini, Ceschin, Morino, Fiorelli, and Gragnani) and Cellular Biotechnology and Hematology (Drs. Mengarelli, Iori, and Arcese), University of Rome "La Sapienza," Italy.
Address correspondence and reprint requests to Dr. G. Antonini, Department of Neurosciences, Viale dell'Università 30, 00185 Rome, Italy.
Background: Bone marrow transplant (BMT) is used for both neoplastic and nonneoplastic diseases. Following BMT, particularly during the first 3 months, patients have a number of neurologic complications. We evaluated the early neurologic complications following BMT and their influence on survival.
Methods: We prospectively followed 115 consecutive patients having BMT for leukemia, for a median period of 90 days after transplantation.
Results: Sixty-four patients (56%) had neurologic complications. Sixteen developed more than one complication. Twenty-seven patients (25%) had major neurologic complications: metabolic encephalopathy (8), seizures (8), psychiatric symptoms (3), cerebral hemorrhage (1), cerebral abscess (1), leukemic meningitis (1), peripheral neuropathies (5), and myopathies (2). Forty patients (35%) had minor complications, including headache (16) and tremor(31). Major neurologic complications occurred after engraftment in most patients. Metabolic encephalopathy correlated with graft-versus-host disease(GVHD) (p < 0.03). Seven percent of patients had generalized seizures that occurred without signs of structural cerebral lesions. Probability of survival at day 90 was lower in patients with than in those without major central nervous system complications (63% versus 87.5%, p < 0.01).
Conclusions: Neurologic complications are frequent during the first 3 months following BMT and affect patient survival. Drug neurotoxicity and acute GVHD are the main factors influencing their occurrence.
Received May 22, 1997. Accepted in final form November 18, 1997.
This article has been cited by other articles:
![]() |
D. Friedman, J. Claassen, and L. J. Hirsch Continuous Electroencephalogram Monitoring in the Intensive Care Unit Anesth. Analg., August 1, 2009; 109(2): 506 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. van de Beek, W. Kremers, R. C. Daly, B. S. Edwards, A. L. Clavell, C. G. A. McGregor, and E. F. M. Wijdicks Effect of Neurologic Complications on Outcome After Heart Transplant Arch Neurol, February 1, 2008; 65(2): 226 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Denier, J. -H. Bourhis, C. Lacroix, S. Koscielny, J. Bosq, R. Sigal, G. Said, and D. Adams Spectrum and prognosis of neurologic complications after hematopoietic transplantation Neurology, December 12, 2006; 67(11): 1990 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gaggero, R. Haupt, M. P. Fondelli, R. De Vescovi, A. Marino, E. Lanino, S. Dallorso, and M. Faraci Intractable Epilepsy Secondary to Cyclosporine Toxicity in Children Undergoing Allogeneic Hematopoietic Bone Marrow Transplantation J Child Neurol, October 1, 2006; 21(10): 861 - 866. [Abstract] [PDF] |
||||
![]() |
D Beckett and J Olliff Non-infectious manifestations of stem cell transplantation Br. J. Radiol., March 1, 2005; 78(927): 272 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ionita, M. Wasay, L. Balos, and R. Bakshi MR Imaging in Toxoplasmosis Encephalitis after Bone Marrow Transplantation: Paucity of Enhancement despite Fulminant Disease AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 270 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sostak, C.S. Padovan, T.A. Yousry, G. Ledderose, H.-J. Kolb, and A. Straube Prospective evaluation of neurological complications after allogeneic bone marrow transplantation Neurology, March 11, 2003; 60(5): 842 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Thuerl, K. Muller, J. Laubenberger, B. Volk, and M. Langer MR Imaging of Autopsy-Proved Paraneoplastic Limbic Encephalitis in Non-Hodgkin Lymphoma AJNR Am. J. Neuroradiol., March 1, 2003; 24(3): 507 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Faraci, E. Lanino, G. Dini, M.P. Fondelli, G. Morreale, S. Dallorso, C. Manzitti, M.G. Calevo, R. Gaggero, E. Castagnola, et al. Severe neurologic complications after hematopoietic stem cell transplantation in children Neurology, December 24, 2002; 59(12): 1895 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
C de Brabander, J Cornelissen, P A E S. Smitt, C. J Vecht, and M J van den Bent Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors J. Neurol. Neurosurg. Psychiatry, January 1, 2000; 68(1): 36 - 40. [Abstract] [Full Text] |
||||
![]() |
C. S. Padovan, K. Bise, J. Hahn, P. Sostak, E. Holler, H.-J. Kolb, and A. Straube Angiitis of the Central Nervous System After Allogeneic Bone Marrow Transplantation? Stroke, August 1, 1999; 30(8): 1651 - 1656. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |